Non-Hodgkin lymphoma (NHL)
- NHL is many diseases—not one regimen
- Histology, stage + molecular subtype drive therapy
- B-cell lymphomas often use anti-CD20–based regimens
- Indolent asymptomatic disease may be observed
- Aggressive lymphomas often require curative-intent combination therapy
- Targeted, antibody + cellular therapies dominate many relapses
Use at a glance
- NHL is many diseases—not one regimen
Monitoring / follow-up
- B-cell lymphomas often use anti-CD20–based regimens
- Indolent asymptomatic disease may be observed
Treatment options
- Aggressive lymphomas often require curative-intent combination therapy
- Targeted, antibody + cellular therapies dominate many relapses
Choosing treatment
- Histology, stage + molecular subtype drive therapy
Self-check
- What is recommended for Non-Hodgkin lymphoma (NHL)?
NHL is many diseases—not one regimen.
Drugs used for this (1)
All clinical uses · Open the interactive console ↗
